Navigation Links
Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile
Date:11/24/2008

-Phase I/II studies summarized-

BELLEVILLE, ON, Nov. 24 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, presented data about its proprietary Mycobacterial Cell Wall-DNA Complex (MCC) - trademarked Urocidin - to an international audience of urologists at the 2008 Societe Internationale d'Urologie (SIU) Congress in Santiago, Chile on Saturday.

The presentation, entitled, "Patients Age in Bladder Cancer Immunotherapy Response and Adverse Events: MCC Experience", was presented by Dr. Francois Charette, Senior Vice-President and Chief Medical Officer of Bioniche Life Sciences Inc.

In his presentation, Dr. Charette summarized the results of Phase I/II clinical studies with MCC, which involved 130 patients with Carcinoma in situ (CIS) high grade bladder cancer, with or without papillary lesions. The majority of these patients (62%) had been previously treated with bacillus Calmette- Guerin (BCG). The average age of the study participants was 73 years. The SIU presentation concluded that MCC has an excellent safety profile in older patients. Furthermore, the complete response rate, a measure of efficacy for bladder cancer, was similar between older and younger patients.

The SIU is the world's only truly international professional organization serving the global community of urologists. Founded in Paris in 1907, the SIU Central Office now serves its members from Montreal, Quebec, Canada. SIU members represent the full spectrum of clinicians and investigators from all subspecialties that come together to diagnose, treat and support patients with urological disease.

Urocidin is currently undergoing clinical testing in a pivotal Phase III clinical trial. In this trial, patients with non-muscle-invasive bladder cancer whose cancer is specifically refractory (unresponsive) to BCG therapy will receive Urocidin in an open label stu
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Bioniche Reports Fiscal 2009 First Quarter
2. Bioniche Allows Conversion of Portion of Revolving Credit Facility
3. Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
4. Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference
5. Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production
6. Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia
7. Bioniche Presents Pre-Clinical Research at Two International Conferences
8. Bioniche Updates re: Mycobacterial Cell Wall Technology Platform
9. Bioniche Reports Fiscal 2008 Third Quarter
10. Bioniche Appoints U.S. President of Food Safety
11. Bioniche Reports the Passing of its Board Chair

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...0 I,m surprised and dismayed by th... every step of my life and my career as an attorne...mbudsman for the Texas Youth Commission, I have up...fessional commitment to the protection, prevention...sonal passion. ,, Of the many concerns that p...
(Date:11/30/2009)...out treatment for blood-borne diseases, researcher...s) -- Many medical students get stuck by needles, ... they often fail to alert hospital authorities, wh... has found. , The researchers interviewed 699 s...hat 415 -- 59 percent -- had experienced needlesti...
(Date:11/30/2009)...ounger, immune cells than sedentary, healthy adult...) -- Studies have shown that exercise can help war...ch shows that the reason why may be found within c...ger telomeres -- DNA at the tips of chromosomes th...than healthy, nonsmoking adults who did not exerci...
(Date:11/30/2009)...LES, Nov. 30 Menopause - it,s an u...th it a host of uncomfortable symptoms that negati...ep, mood swings, weight gain , night sweats and l...s of menopause and perimenopause. What,s worse, m...n years before actual menopause occurs (perimenopa...
(Date:11/30/2009)...by Merck, the unique online and mobile tool empowe... treatment decisions ,, ARLINGTON, Va., Nov. 3...dy.com ), the #1 HIV/AIDS resource online, today l...ol offering HIV/AIDS-infected patients the ability...e tool, created with sponsorship from Merck, is av...
Breaking Medicine News(10 mins):Health News:Independent Ombudsman for Texas Youth Commission Resigns 2Health News:Med Students Often Fail to Report Needlestick Injuries 2Health News:Exercise Guards White Blood Cells Against Aging 2Health News:Exercise Guards White Blood Cells Against Aging 3Health News:Anti-Aging Institute of California Offers New Natural Solution for Menopause Symptoms 2Health News:TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements 2
...tions, researcher says , , FRIDAY, Nov. 2...les the risk of prostate cancer in black men has b...could lead to new treatments. , Almost twice as ma...or prostate cancer. One of these variants, on the ...
... Technologies,Inc. (Amex: PTN ) today announced t...Renshaw 9th Annual Healthcare Conference at the Ne...r 5, 2007 at 4:45 PM ET. Carl Spana, Ph.D., Presi...ve audio broadcast or the subsequent,archived reco...
...re, the 15th anniversary,celebration benefiting re...enry Ford Hospital, will be held at 6 p.m. Thursda...Warren. This year,s celebration will honor Bloomf...performance by the,Scintas, voted one of the top f...
... heart disease risk before and after pregnancy, , ... with cardiovascular risk markers are at heightene...nd pregnant women who do develop preeclampsia are ...od pressure develops during the second half of pre...
...Coalition to honor Hispanic entrepreneurs in ...LUMBUS, Ga., Nov. 2 Today, four exemplary Hispani...c Award for making a,difference in Texas. Vernon H...nistration, honored each winner,during an awards c...
...ce from Australia and New Zealand, COPPELL, Texas... a leading developer and provider of dietary,suppl...Australasian,Convention at the Acer Arena in Sydne...We enjoyed introducing the Australasian market to ...
Other Medicine News:Health News:Gene Variant Doubles Risk of Prostate Cancer in Black Men 2Health News:Preeclampsia Linked to Heart Disease Risk 2Health News:Preeclampsia Linked to Heart Disease Risk 3Health News:Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas 2Health News:Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas 3Health News:Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas 4Health News:Mannatech Hosts Australasian Convention 2Health News:Mannatech Hosts Australasian Convention 3
(Date:11/30/2009)... N.J., Nov. 30 MedQuist ...ology-enabled clinical documentation services, tod...Nuance Communications, Inc. (Nuance) under which M...ch recognition engine and processing software for ... front-end speech recognition application for all ...
(Date:11/30/2009)...YORK, Nov. 30 Reportlinker.com ann...ble in its catalogue: ,, Diabetes Diagnostics ...eportlinker.com/p0164347/Diabetes-Diagnostics---A-...agnosis market is driven by a steady increase in t...in the developed and developing parts of the world...
(Date:11/30/2009).... 30 Dr. Jocelyn Rapelyea, Associa...George Washington University Medical Center in Was...ntified with Breast-Specific Gamma Imaging (BSGI) ...for needle biopsy as well, as for pre-operative lo...ological Society of North America (RSNA). ,, BS...
Breaking Medicine Technology:MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 4Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 5Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 6Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 7Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 8Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 9Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Disability Rates Continue Steady Climb According to CDAs 2008 Disability Claims Review 56752 1Disability Rates Continue Steady Climb According to CDAs 2008 Disability Claims Review 56752 2Disability Rates Continue Steady Climb According to CDAs 2008 Disability Claims Review 56752 3Prime Retail Launches Operation Shop Pink 56749 1Prime Retail Launches Operation Shop Pink 56749 2Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 1Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 2Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 3Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 4
...Reported Safety & Tolerability Profile,in Subj... CHICAGO, June 25, 2007 /PRNewswire-FirstCall/ -- ...eeting of the American Diabetes,Association demons...l-peptidase-4 (DPP-4) in development by Bristol-My...n with metformin,exhibited a statistically signif...
...NYVALE, Calif., June 27, 2007,/PRNewswire-FirstCal...ary results from two open-label, multi-center Phas...f Xcytrin(R),(motexafin gadolinium) Injection, the...with Alimta(R) (pemetrexed) and in,combination wit...nt,for patients with non-small cell lung cancer (N...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 2Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 3Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 4Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 5
... 1064 is a laser system with one single wavelength... continuous intensities of either 60 W or 100 W, a...l techniques. This laser is the classical version ...rom hospitals and clinics which would like to have...
...3.0 is the most advanced system for laser therapy ...s a patented optical fiber handpiece that allows t...ision, recovering up to the 20% of the energy refl...averted thanks to a special gel which optimizes th...
... 25 SS is a high power CO2 laser particularly indi...are possible with this device in rheumatology, der... SS displays the selected fluence and performs a d...internal power meter. Moreover, an auto shut-off ...
SmartCryo
Medicine Products: